| Dr Kyle Collingwood Edwards, DO | |
|
1200 N Beaver St, Flagstaff, AZ 86001-3118 | |
| (928) 773-2451 | |
| (928) 214-2925 |
| Full Name | Dr Kyle Collingwood Edwards |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 12 Years |
| Location | 1200 N Beaver St, Flagstaff, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184970592 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 006654 (Arizona) | Secondary |
| 208M00000X | Hospitalist | 006654 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St. Mary's Hospital | Tucson, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cogent Healthcare Of Arizona Pc | 0648441006 | 66 |
News Archive
ValueOptions, Inc. a health improvement company specializing in mental and emotional well-being and recovery, and Genomind, a personalized medicine company, today announced an innovative study that uses pharmacogenomic testing to treat patients diagnosed with psychotic disorders, including schizophrenia and bipolar disorder.
Seven-time PGA TOUR winner Steve Stricker has recently designated a check in the amount of $10,000 to the National Fragile X Foundation. This contribution is a portion of the charitable proceeds generated from The Presidents Cup 2009 at Harding Park Golf Course in San Francisco, California, in which Stricker participated as a member of the victorious U.S. Team for the third time in his career.
Research on the same protein that was a primary mediator of the birth defects caused by thalidomide now holds hope in the battle against multiple myeloma, says the study's senior investigator, Keith Stewart, M.B., Ch.B. of Mayo Clinic in Arizona. Dr. Stewart presented the results at the 53rd annual meeting of the American Society of Hematology in San Diego.
California Stem Cell, Inc. (CSC) and Families of Spinal Muscular Atrophy (FSMA) announced today that CSC has filed an investigational new drug (IND) application with the US Food and Drug Administration (FDA) for approval to commence a Phase I safety study on a jointly-developed stem cell-derived motor neuron transplantation therapy for Spinal Muscular Atrophy (SMA) Type I.
An innovative device which cancels out the noise of the dental drill could spell the end of people's anxiety about trips to the dentist, according to experts at King's College London, Brunel University and London South Bank University, who pioneered the invention.
› Verified 8 days ago
| Entity Name | Hospitalists Of Arizona, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578564860 PECOS PAC ID: 2163335290 Enrollment ID: O20031112000571 |
News Archive
ValueOptions, Inc. a health improvement company specializing in mental and emotional well-being and recovery, and Genomind, a personalized medicine company, today announced an innovative study that uses pharmacogenomic testing to treat patients diagnosed with psychotic disorders, including schizophrenia and bipolar disorder.
Seven-time PGA TOUR winner Steve Stricker has recently designated a check in the amount of $10,000 to the National Fragile X Foundation. This contribution is a portion of the charitable proceeds generated from The Presidents Cup 2009 at Harding Park Golf Course in San Francisco, California, in which Stricker participated as a member of the victorious U.S. Team for the third time in his career.
Research on the same protein that was a primary mediator of the birth defects caused by thalidomide now holds hope in the battle against multiple myeloma, says the study's senior investigator, Keith Stewart, M.B., Ch.B. of Mayo Clinic in Arizona. Dr. Stewart presented the results at the 53rd annual meeting of the American Society of Hematology in San Diego.
California Stem Cell, Inc. (CSC) and Families of Spinal Muscular Atrophy (FSMA) announced today that CSC has filed an investigational new drug (IND) application with the US Food and Drug Administration (FDA) for approval to commence a Phase I safety study on a jointly-developed stem cell-derived motor neuron transplantation therapy for Spinal Muscular Atrophy (SMA) Type I.
An innovative device which cancels out the noise of the dental drill could spell the end of people's anxiety about trips to the dentist, according to experts at King's College London, Brunel University and London South Bank University, who pioneered the invention.
› Verified 8 days ago
| Entity Name | American Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609869908 PECOS PAC ID: 3577467463 Enrollment ID: O20031121000688 |
News Archive
ValueOptions, Inc. a health improvement company specializing in mental and emotional well-being and recovery, and Genomind, a personalized medicine company, today announced an innovative study that uses pharmacogenomic testing to treat patients diagnosed with psychotic disorders, including schizophrenia and bipolar disorder.
Seven-time PGA TOUR winner Steve Stricker has recently designated a check in the amount of $10,000 to the National Fragile X Foundation. This contribution is a portion of the charitable proceeds generated from The Presidents Cup 2009 at Harding Park Golf Course in San Francisco, California, in which Stricker participated as a member of the victorious U.S. Team for the third time in his career.
Research on the same protein that was a primary mediator of the birth defects caused by thalidomide now holds hope in the battle against multiple myeloma, says the study's senior investigator, Keith Stewart, M.B., Ch.B. of Mayo Clinic in Arizona. Dr. Stewart presented the results at the 53rd annual meeting of the American Society of Hematology in San Diego.
California Stem Cell, Inc. (CSC) and Families of Spinal Muscular Atrophy (FSMA) announced today that CSC has filed an investigational new drug (IND) application with the US Food and Drug Administration (FDA) for approval to commence a Phase I safety study on a jointly-developed stem cell-derived motor neuron transplantation therapy for Spinal Muscular Atrophy (SMA) Type I.
An innovative device which cancels out the noise of the dental drill could spell the end of people's anxiety about trips to the dentist, according to experts at King's College London, Brunel University and London South Bank University, who pioneered the invention.
› Verified 8 days ago
| Entity Name | Cogent Healthcare Of Arizona Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568758266 PECOS PAC ID: 0648441006 Enrollment ID: O20110915000843 |
News Archive
ValueOptions, Inc. a health improvement company specializing in mental and emotional well-being and recovery, and Genomind, a personalized medicine company, today announced an innovative study that uses pharmacogenomic testing to treat patients diagnosed with psychotic disorders, including schizophrenia and bipolar disorder.
Seven-time PGA TOUR winner Steve Stricker has recently designated a check in the amount of $10,000 to the National Fragile X Foundation. This contribution is a portion of the charitable proceeds generated from The Presidents Cup 2009 at Harding Park Golf Course in San Francisco, California, in which Stricker participated as a member of the victorious U.S. Team for the third time in his career.
Research on the same protein that was a primary mediator of the birth defects caused by thalidomide now holds hope in the battle against multiple myeloma, says the study's senior investigator, Keith Stewart, M.B., Ch.B. of Mayo Clinic in Arizona. Dr. Stewart presented the results at the 53rd annual meeting of the American Society of Hematology in San Diego.
California Stem Cell, Inc. (CSC) and Families of Spinal Muscular Atrophy (FSMA) announced today that CSC has filed an investigational new drug (IND) application with the US Food and Drug Administration (FDA) for approval to commence a Phase I safety study on a jointly-developed stem cell-derived motor neuron transplantation therapy for Spinal Muscular Atrophy (SMA) Type I.
An innovative device which cancels out the noise of the dental drill could spell the end of people's anxiety about trips to the dentist, according to experts at King's College London, Brunel University and London South Bank University, who pioneered the invention.
› Verified 8 days ago
| Entity Name | Northern Arizona Healthcare Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669914552 PECOS PAC ID: 3577473362 Enrollment ID: O20170801003409 |
News Archive
ValueOptions, Inc. a health improvement company specializing in mental and emotional well-being and recovery, and Genomind, a personalized medicine company, today announced an innovative study that uses pharmacogenomic testing to treat patients diagnosed with psychotic disorders, including schizophrenia and bipolar disorder.
Seven-time PGA TOUR winner Steve Stricker has recently designated a check in the amount of $10,000 to the National Fragile X Foundation. This contribution is a portion of the charitable proceeds generated from The Presidents Cup 2009 at Harding Park Golf Course in San Francisco, California, in which Stricker participated as a member of the victorious U.S. Team for the third time in his career.
Research on the same protein that was a primary mediator of the birth defects caused by thalidomide now holds hope in the battle against multiple myeloma, says the study's senior investigator, Keith Stewart, M.B., Ch.B. of Mayo Clinic in Arizona. Dr. Stewart presented the results at the 53rd annual meeting of the American Society of Hematology in San Diego.
California Stem Cell, Inc. (CSC) and Families of Spinal Muscular Atrophy (FSMA) announced today that CSC has filed an investigational new drug (IND) application with the US Food and Drug Administration (FDA) for approval to commence a Phase I safety study on a jointly-developed stem cell-derived motor neuron transplantation therapy for Spinal Muscular Atrophy (SMA) Type I.
An innovative device which cancels out the noise of the dental drill could spell the end of people's anxiety about trips to the dentist, according to experts at King's College London, Brunel University and London South Bank University, who pioneered the invention.
› Verified 8 days ago
| Entity Name | Hospitalist Medicine Physicians Of Arizona - Tucson Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629557798 PECOS PAC ID: 7113279886 Enrollment ID: O20181008001135 |
News Archive
ValueOptions, Inc. a health improvement company specializing in mental and emotional well-being and recovery, and Genomind, a personalized medicine company, today announced an innovative study that uses pharmacogenomic testing to treat patients diagnosed with psychotic disorders, including schizophrenia and bipolar disorder.
Seven-time PGA TOUR winner Steve Stricker has recently designated a check in the amount of $10,000 to the National Fragile X Foundation. This contribution is a portion of the charitable proceeds generated from The Presidents Cup 2009 at Harding Park Golf Course in San Francisco, California, in which Stricker participated as a member of the victorious U.S. Team for the third time in his career.
Research on the same protein that was a primary mediator of the birth defects caused by thalidomide now holds hope in the battle against multiple myeloma, says the study's senior investigator, Keith Stewart, M.B., Ch.B. of Mayo Clinic in Arizona. Dr. Stewart presented the results at the 53rd annual meeting of the American Society of Hematology in San Diego.
California Stem Cell, Inc. (CSC) and Families of Spinal Muscular Atrophy (FSMA) announced today that CSC has filed an investigational new drug (IND) application with the US Food and Drug Administration (FDA) for approval to commence a Phase I safety study on a jointly-developed stem cell-derived motor neuron transplantation therapy for Spinal Muscular Atrophy (SMA) Type I.
An innovative device which cancels out the noise of the dental drill could spell the end of people's anxiety about trips to the dentist, according to experts at King's College London, Brunel University and London South Bank University, who pioneered the invention.
› Verified 8 days ago
| Entity Name | Hospitalist Medicine Physicians Of Arizona - Tcs |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538758909 PECOS PAC ID: 3274940028 Enrollment ID: O20210324000655 |
News Archive
ValueOptions, Inc. a health improvement company specializing in mental and emotional well-being and recovery, and Genomind, a personalized medicine company, today announced an innovative study that uses pharmacogenomic testing to treat patients diagnosed with psychotic disorders, including schizophrenia and bipolar disorder.
Seven-time PGA TOUR winner Steve Stricker has recently designated a check in the amount of $10,000 to the National Fragile X Foundation. This contribution is a portion of the charitable proceeds generated from The Presidents Cup 2009 at Harding Park Golf Course in San Francisco, California, in which Stricker participated as a member of the victorious U.S. Team for the third time in his career.
Research on the same protein that was a primary mediator of the birth defects caused by thalidomide now holds hope in the battle against multiple myeloma, says the study's senior investigator, Keith Stewart, M.B., Ch.B. of Mayo Clinic in Arizona. Dr. Stewart presented the results at the 53rd annual meeting of the American Society of Hematology in San Diego.
California Stem Cell, Inc. (CSC) and Families of Spinal Muscular Atrophy (FSMA) announced today that CSC has filed an investigational new drug (IND) application with the US Food and Drug Administration (FDA) for approval to commence a Phase I safety study on a jointly-developed stem cell-derived motor neuron transplantation therapy for Spinal Muscular Atrophy (SMA) Type I.
An innovative device which cancels out the noise of the dental drill could spell the end of people's anxiety about trips to the dentist, according to experts at King's College London, Brunel University and London South Bank University, who pioneered the invention.
› Verified 8 days ago
| Entity Name | App Of Southern Arizona Hm Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518542679 PECOS PAC ID: 7113335159 Enrollment ID: O20210413000209 |
News Archive
ValueOptions, Inc. a health improvement company specializing in mental and emotional well-being and recovery, and Genomind, a personalized medicine company, today announced an innovative study that uses pharmacogenomic testing to treat patients diagnosed with psychotic disorders, including schizophrenia and bipolar disorder.
Seven-time PGA TOUR winner Steve Stricker has recently designated a check in the amount of $10,000 to the National Fragile X Foundation. This contribution is a portion of the charitable proceeds generated from The Presidents Cup 2009 at Harding Park Golf Course in San Francisco, California, in which Stricker participated as a member of the victorious U.S. Team for the third time in his career.
Research on the same protein that was a primary mediator of the birth defects caused by thalidomide now holds hope in the battle against multiple myeloma, says the study's senior investigator, Keith Stewart, M.B., Ch.B. of Mayo Clinic in Arizona. Dr. Stewart presented the results at the 53rd annual meeting of the American Society of Hematology in San Diego.
California Stem Cell, Inc. (CSC) and Families of Spinal Muscular Atrophy (FSMA) announced today that CSC has filed an investigational new drug (IND) application with the US Food and Drug Administration (FDA) for approval to commence a Phase I safety study on a jointly-developed stem cell-derived motor neuron transplantation therapy for Spinal Muscular Atrophy (SMA) Type I.
An innovative device which cancels out the noise of the dental drill could spell the end of people's anxiety about trips to the dentist, according to experts at King's College London, Brunel University and London South Bank University, who pioneered the invention.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kyle Collingwood Edwards, DO 1200 N Beaver St, Flagstaff, AZ 86001-3118 Ph: (928) 213-6235 | Dr Kyle Collingwood Edwards, DO 1200 N Beaver St, Flagstaff, AZ 86001-3118 Ph: (928) 773-2451 |
News Archive
ValueOptions, Inc. a health improvement company specializing in mental and emotional well-being and recovery, and Genomind, a personalized medicine company, today announced an innovative study that uses pharmacogenomic testing to treat patients diagnosed with psychotic disorders, including schizophrenia and bipolar disorder.
Seven-time PGA TOUR winner Steve Stricker has recently designated a check in the amount of $10,000 to the National Fragile X Foundation. This contribution is a portion of the charitable proceeds generated from The Presidents Cup 2009 at Harding Park Golf Course in San Francisco, California, in which Stricker participated as a member of the victorious U.S. Team for the third time in his career.
Research on the same protein that was a primary mediator of the birth defects caused by thalidomide now holds hope in the battle against multiple myeloma, says the study's senior investigator, Keith Stewart, M.B., Ch.B. of Mayo Clinic in Arizona. Dr. Stewart presented the results at the 53rd annual meeting of the American Society of Hematology in San Diego.
California Stem Cell, Inc. (CSC) and Families of Spinal Muscular Atrophy (FSMA) announced today that CSC has filed an investigational new drug (IND) application with the US Food and Drug Administration (FDA) for approval to commence a Phase I safety study on a jointly-developed stem cell-derived motor neuron transplantation therapy for Spinal Muscular Atrophy (SMA) Type I.
An innovative device which cancels out the noise of the dental drill could spell the end of people's anxiety about trips to the dentist, according to experts at King's College London, Brunel University and London South Bank University, who pioneered the invention.
› Verified 8 days ago
Dr. Sanya Aysha Kayani, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-214-2920 Fax: 928-214-2925 | |
Brandon Robert Thomas, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-779-3366 | |
Dr. Christine Marie Kneisel, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-214-2920 Fax: 928-214-2925 | |
Edward G Paul, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2920 N 4th St, Flagstaff, AZ 86004 Phone: 928-522-9400 Fax: 928-774-4808 | |
Dr. Marian Lacy, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-213-6235 Fax: 928-213-6292 | |
Audrey Lee, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-214-2920 Fax: 928-214-2925 | |
Dr. Matthew Randolph, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-214-2920 |